Skip to main content

Published locations for In psoriasis, risankizumab outperforms adalimumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. In psoriasis, risankizumab outperforms adalimumab

User login

  • Reset your password
  • /content/psoriasis-risankizumab-outperforms-adalimumab
  • /edermatologynews/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /familypracticenews/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /internalmedicinenews/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /internalmedicine/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /dermatology/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /familymedicine/article/204590/psoriasis/psoriasis-risankizumab-outperforms-adalimumab
  • /dermatology/psoriasiscollection/article/204590/psoriasis/psoriasis-risankizumab-outperforms